vs
Ardmore Shipping Corp（ASC）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
Ardmore Shipping Corp的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.4倍（$81.2M vs $57.3M），Ardmore Shipping Corp净利率更高（15.7% vs -83.0%，领先98.7%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs -15.5%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs -6.0%）
阿德莫尔航运是一家全球化海上运输企业，持有并运营中型成品油轮与化学品运输船队，可为全球能源、化工及贸易领域客户提供石油产品、特种化学品及其他散装液态货物的海运服务。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
ASC vs RYTM — 直观对比
营收规模更大
ASC
是对方的1.4倍
$57.3M
营收增速更快
RYTM
高出52.3%
-15.5%
净利率更高
ASC
高出98.7%
-83.0%
两年增速更快
RYTM
近两年复合增速
-6.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $81.2M | $57.3M |
| 净利润 | $12.8M | $-47.5M |
| 毛利率 | — | 91.6% |
| 营业利润率 | 16.1% | -82.2% |
| 净利率 | 15.7% | -83.0% |
| 营收同比 | -15.5% | 36.9% |
| 净利润同比 | -47.0% | -9.6% |
| 每股收益（稀释后） | $0.30 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASCRYTM
| Q4 25 | — | $57.3M | ||
| Q3 25 | $81.2M | $51.3M | ||
| Q2 25 | $72.0M | $48.5M | ||
| Q1 25 | $74.0M | $32.7M | ||
| Q4 24 | — | $41.8M | ||
| Q3 24 | $96.1M | $33.3M | ||
| Q2 24 | $121.3M | $29.1M | ||
| Q1 24 | $106.3M | $26.0M |
净利润ASCRYTM
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $12.8M | $-52.9M | ||
| Q2 25 | $9.6M | $-46.6M | ||
| Q1 25 | $6.3M | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $24.1M | $-43.6M | ||
| Q2 24 | $62.7M | $-32.3M | ||
| Q1 24 | $39.2M | $-141.4M |
毛利率ASCRYTM
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
营业利润率ASCRYTM
| Q4 25 | — | -82.2% | ||
| Q3 25 | 16.1% | -102.6% | ||
| Q2 25 | 13.5% | -93.4% | ||
| Q1 25 | 8.6% | -143.7% | ||
| Q4 24 | — | -98.6% | ||
| Q3 24 | 25.4% | -132.0% | ||
| Q2 24 | 51.3% | -139.2% | ||
| Q1 24 | 37.2% | -538.7% |
净利率ASCRYTM
| Q4 25 | — | -83.0% | ||
| Q3 25 | 15.7% | -103.1% | ||
| Q2 25 | 13.3% | -96.1% | ||
| Q1 25 | 8.5% | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | 25.1% | -131.2% | ||
| Q2 24 | 51.7% | -110.9% | ||
| Q1 24 | 36.9% | -544.4% |
每股收益（稀释后）ASCRYTM
| Q4 25 | — | $-0.73 | ||
| Q3 25 | $0.30 | $-0.82 | ||
| Q2 25 | $0.22 | $-0.75 | ||
| Q1 25 | $0.14 | $-0.81 | ||
| Q4 24 | — | $-0.71 | ||
| Q3 24 | $0.55 | $-0.73 | ||
| Q2 24 | $1.47 | $-0.55 | ||
| Q1 24 | $0.92 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $388.9M |
| 总债务越低越好 | $116.1M | — |
| 股东权益账面价值 | $628.2M | $139.1M |
| 总资产 | $799.8M | $480.2M |
| 负债/权益比越低杠杆越低 | 0.18× | — |
8季度趋势，按日历期对齐
现金及短期投资ASCRYTM
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
总债务ASCRYTM
| Q4 25 | — | — | ||
| Q3 25 | $116.1M | — | ||
| Q2 25 | $25.0M | — | ||
| Q1 25 | $20.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $22.5M | — | ||
| Q2 24 | $44.2M | — | ||
| Q1 24 | $23.1M | — |
股东权益ASCRYTM
| Q4 25 | — | $139.1M | ||
| Q3 25 | $628.2M | $148.8M | ||
| Q2 25 | $618.3M | $-11.9M | ||
| Q1 25 | $610.7M | $18.9M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | $627.0M | $11.2M | ||
| Q2 24 | $617.7M | $39.3M | ||
| Q1 24 | $567.9M | $61.6M |
总资产ASCRYTM
| Q4 25 | — | $480.2M | ||
| Q3 25 | $799.8M | $506.9M | ||
| Q2 25 | $703.8M | $372.7M | ||
| Q1 25 | $690.4M | $386.7M | ||
| Q4 24 | — | $392.3M | ||
| Q3 24 | $722.8M | $363.6M | ||
| Q2 24 | $742.0M | $381.8M | ||
| Q1 24 | $704.1M | $258.7M |
负债/权益比ASCRYTM
| Q4 25 | — | — | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.9M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASCRYTM
| Q4 25 | — | $-25.4M | ||
| Q3 25 | $17.9M | $-26.6M | ||
| Q2 25 | $11.2M | $-23.3M | ||
| Q1 25 | $26.3M | $-40.4M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | $39.9M | $-25.2M | ||
| Q2 24 | $48.4M | $-29.1M | ||
| Q1 24 | $49.2M | $-40.7M |
现金转化率ASCRYTM
| Q4 25 | — | — | ||
| Q3 25 | 1.40× | — | ||
| Q2 25 | 1.17× | — | ||
| Q1 25 | 4.20× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 1.25× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
